Although the primary “driving force” leading to the changes in AS2 is still elusive, it is notorious the fact that the variants implicated in CdLS and cancer are roughly located in the pathway that connects AS1 to AS2 (Fig. 5a). This evidence concerns the gene PTGDR and cancer.